New syringe design not particularly effective at curbing spread of Hepatitis C virus

Researchers examined the internal design of syringes to see if variations affected the transmission of hepatitis C virus.
As many as 21 million people worldwide inject drugs, putting them at heightened risk for infection from blood-borne pathogens such as the hepatitis C virus (HCV), especially if syringes are shared.

A newer type of syringe designed to reduce HCV transmission by decreasing the so-called dead space